FDA New, GMP Do
Clinical Phase II, III IntermediatesGMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
CHF-1255, 733712-20-4, CHF-1255 Intermediate 52644-01-6, stock 489.4g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply.
CHF-1255, 733712-20-4, CHF-1255 Intermediate 62959-84-6, stock 259.2g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply.
CHF-1255, 733712-20-4, CHF-1255 Intermediate /, stock 834.6g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply.
CHF-1255, 733712-20-4, CHF-1255 Intermediate 733712-20-4, stock 908.5g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply.
